Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Shimon I et al. – The authors' results showed that mTOR inhibitors potently inhibit pituitary cell proliferation, suggesting that mTOR inhibition may be a promising anti–proliferative therapy for pituitary adenomas. This therapeutic manipulation may have beneficial effects particularly for patients harboring invasive pituitary tumors resistant to current treatments.

Related Articles

E2F1 Induces Pituitary Tumor Transforming Gene (PTTG1) Expression in Human Pituitary Tumors
Molecular Endocrinology, 11/02/09    Relevance Score: 69%

Regulation of Pituitary Function by Cytokines
Hormone Research, 10/27/09    Relevance Score: 68%

Medical treatment of Cushing's disease: Overview and recent findings
International Journal of General Medicine, 10/21/09    Relevance Score: 67%

Pituitary metastasis of Merkel cell carcinoma
Journal of Neuro-Oncology, 10/28/09    Relevance Score: 66%

Predicting Recurrence of Nonfunctioning Pituitary Adenomas
Journal of Clinical Endocrinology and Metabolism, 10/15/09    Relevance Score: 66%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address